NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4] - CAGS

NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]

HGVS Expressions

NG_021240.1:g.17637ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]
NM_173841.3:c.215-516ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]
NC_000002.12:g.113130529ATCCTGGGGAAAGTGAGGGAAATATGGACATCACATGGAACAACATCCAGGAGACTCAGGCCTCTAGGAGTAACTGGGTAGTGTGC[4]

Associated Genes

Interleukin 1 Receptor Antagonist

Back to search Result

CTGA Clinical Significance

Association

Variant Type

Reference Allele

dbSNP

Epidemiology in the Arab World

United Arab Emirates

Show entries

Search:

Subject ID	Country of Origin	Allele Count	CTGA Clinical Significance	Condition(s)	Reference	Remarks
125853.G.38.1	United Arab Emirates	400	Association	Type 2 Diabetes Mellitus	Al-Safar et al. 2015	271 Emiratis with Type 2 DM.
125853.G.38.2	United Arab Emirates	276			Al-Safar et al. 2015	215 healthy controls

Download Table

Contributors

Pratibha Nair: 17.05.2022

Edit History

Sami Bizzari: 30.01.2023
Sayeeda Hana: 13.01.2023
Pratibha Nair: 17.05.2022

Back to search Result

© CAGS 2025. All rights reserved.

© CAGS 2025. All rights reserved.